← Back to Clinical Trials
Recruiting NCT07205003

NCT07205003 Evaluation of the Link Between Carotid Arterial Wall Viscosity and Major Neurocognitive Disorders

◆ AI Clinical Summary
Plain-language summary for patients
Clinical Trial Summary
NCT ID NCT07205003
Status Recruiting
Phase
Sponsor University Hospital, Rouen
Condition Neurocognitive Disorders
Study Type OBSERVATIONAL
Enrollment 140 participants
Start Date 2022-02-15
Primary Completion 2027-11-15

Eligibility & Interventions

Sex All sexes
Min Age 70 Years
Max Age N/A
Study Type OBSERVATIONAL
Interventions
Assessment of carotid wall viscosity in patients with vascular dementiaAssessment of carotid wall viscosity in patients with Alzheimer's diseaseAssessment of carotid wall viscosity in patients not presenting dementia.

Eligibility Fast-Check

Enter your details for a quick preliminary check. This does not replace medical advice.

What to Expect as a Participant

This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.

This trial targets 140 participants in total. It began in 2022-02-15 with a primary completion date of 2027-11-15.

⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.

Brief Summary

The mechanical behavior of conductance arteries is viscoelastic. While the elastic component has been extensively studied, the viscous component has often been neglected for methodological reasons and also because it was considered weak. Unlike a purely elastic solid, which exhibits instantaneous deformation/relaxation upon application/discontinuation of a force, a viscoelastic solid is characterized, from a mechanical point of view, by a delay between the application or discontinuation of the force and deformation. Thus, at the arterial level, the elasticity of the arterial wall allows the internal diameter to increase proportionally to the blood pressure during systole. The viscous component will induce a delay in diameter restoration, resulting in a larger diameter at each pressure level during the diastolic phase compared to the systolic phase. This results in a shift between the systolic and diastolic curves of the pressure-diameter relationship, creating a hysteresis loop. From a thermodynamic point of view, while a purely elastic material fully restores the energy stored during the loading phase, viscoelastic arteries will incompletely restore this energy. Thus, the surface of the hysteresis loop reflects the energy dissipated during each cardiac cycle (WV), and the area under the loading phase curve represents the energy stored by the arterial wall (WE) during the latter. Thus, arterial wall viscosity (APV) can be expressed either as the absolute value of WV or as a function of the stored energy (WV/WE). Physiologically, this energy loss is low. Its increase could be accompanied by excessive energy dissipation, leading to increased cardiac work and cardio-circulatory decoupling. Conversely, low parietal viscosity could lead to damage to peripheral organs by excessive transmission of pulsatile energy to the periphery due to lack of damping.

Eligibility Criteria

Inclusion Criteria: * Age over 70 * Memory consultation consultant (neurology or geriatrics) * Brain MRI less than one year old or planned as part of the cognitive assessment performed. * Patient diagnosed with Alzheimer's disease according to DSM-5 criteria or vascular dementia according to DSM-5 criteria, or presenting a memory complaint without evidence of a dementia-related condition. * No objection from the patient or their caregiver. * Patient covered by a health insurance plan Exclusion Criteria: * Known unilateral or bilateral carotid stenosis or history of carotid surgery * Permanent CA/AF * Patient presenting with confusion * Known psychiatric illness (severe depression, psychosis, etc.) * Non-vascular, non-Alzheimer's dementia (e.g., Lewy Body Dementia, Parkinsonian Dementia, Progressive Supranuclear Palsy) * Refusal to participate * MMS less than or equal to 10 * Contraindication to performing an MRI * Any acute decompensated pathology * Patient under guardianship or curatorship

Contact & Investigator

Central Contact

Frédéric FR ROCA, Doctor

✉ Frederic.Roca@chu-rouen.fr

📞 02 32 88 05 39

Frequently Asked Questions

Who can join the NCT07205003 clinical trial?

This trial is open to participants of all sexes, aged 70 Years or older, studying Neurocognitive Disorders. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.

Is NCT07205003 currently recruiting?

Yes, NCT07205003 is actively recruiting participants. Contact the research team at Frederic.Roca@chu-rouen.fr for enrollment information.

Where is the NCT07205003 trial being conducted?

This trial is being conducted at Rouen, France.

Who is sponsoring the NCT07205003 clinical trial?

NCT07205003 is sponsored by University Hospital, Rouen. The trial plans to enroll 140 participants.

Related Trials

ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: July 2026  ·  Data Methodology